-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Pharmacological intervention
-
Monoclonal antibodies
-
Temelimab
-
Adults (18-64 years)
-
General population
-
Hospital
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Outpatient clinic
-
Primary care
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
Fragile population
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Acute COVID-19
-
Pharmacological intervention
-
Antivirals
-
Nirmatrelvir/Ritonavir
-
Molnupiravir
-
Adults (18-64 years)
-
General population
-
SARS-CoV-2
-
Post-COVID-19
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
SARS-CoV-2
-
Post-COVID-19
-
Non pharmacological intervention
-
Rehabilitation
-
Fimo Health App
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post-COVID-19